Canada markets close in 5 hours 1 minute
  • S&P/TSX

    20,148.86
    -472.53 (-2.29%)
     
  • S&P 500

    4,302.91
    -95.03 (-2.16%)
     
  • DOW

    33,683.50
    -581.87 (-1.70%)
     
  • CAD/USD

    0.7899
    -0.0049 (-0.62%)
     
  • CRUDE OIL

    83.22
    -1.92 (-2.26%)
     
  • BTC-CAD

    43,384.94
    -1,537.89 (-3.42%)
     
  • CMC Crypto 200

    779.95
    -30.65 (-3.78%)
     
  • GOLD FUTURES

    1,833.80
    +2.00 (+0.11%)
     
  • RUSSELL 2000

    1,961.20
    -26.72 (-1.34%)
     
  • 10-Yr Bond

    1.7250
    -0.0220 (-1.26%)
     
  • NASDAQ

    13,426.40
    -342.52 (-2.49%)
     
  • VOLATILITY

    33.96
    +5.11 (+17.71%)
     
  • FTSE

    7,325.61
    -168.52 (-2.25%)
     
  • NIKKEI 225

    27,588.37
    +66.11 (+0.24%)
     
  • CAD/EUR

    0.6982
    -0.0022 (-0.31%)
     

Is a Surprise Coming for Axcella Health (AXLA) This Earnings Season?

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • AXLA

Investors are always looking for stocks that are poised to beat at earnings season and Axcella Health Inc. AXLA may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.

That is because Axcella Health is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for AXLA in this report.

In fact, the Most Accurate Estimate for the current quarter is currently at a loss of 43 cents per share for AXLA, compared to a broader Zacks Consensus Estimate of a loss of 45 cents per share. This suggests that analysts have very recently bumped up their estimates for AXLA, giving the stock a Zacks Earnings ESP of +4.18% heading into earnings season.

Axcella Health Inc. Price and EPS Surprise

Axcella Health Inc. Price and EPS Surprise
Axcella Health Inc. Price and EPS Surprise

Axcella Health Inc. price-eps-surprise | Axcella Health Inc. Quote

Why is this Important?

A positive reading for the Zacks Earnings ESP has proven to be very powerful in producing both positive surprises, and outperforming the market. Our recent 10-year backtest shows that stocks that have a positive Earnings ESP and a Zacks Rank #3 (Hold) or better show a positive surprise nearly 70% of the time, and have returned over 28% on average in annual returns (see more Top Earnings ESP stocks here).

Given that AXLA has a Zacks Rank #3 and an ESP in positive territory, investors might want to consider this stock ahead of earnings. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Clearly, recent earnings estimate revisions suggest that good things are ahead for Axcella Health, and that a beat might be in the cards for the upcoming report.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Axcella Health Inc. (AXLA) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting